These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8609541)

  • 21. The effect of exposure to mupirocin on the survival and recovery of sensitive Staphylococcus aureus strains.
    Barr JG; Hogg GM; Smyth ET
    Ulster Med J; 1988 Apr; 57(1):50-7. PubMed ID: 3138804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections.
    Hurdle JG; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2004 Aug; 54(2):549-52. PubMed ID: 15243028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mupirocin resistance.
    Patel JB; Gorwitz RJ; Jernigan JA
    Clin Infect Dis; 2009 Sep; 49(6):935-41. PubMed ID: 19673644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus aureus highly resistant to mupirocin is now common in Auckland.
    Skellem P; Toy G; Lang S
    N Z Med J; 1998 Mar; 111(1061):82. PubMed ID: 9549560
    [No Abstract]   [Full Text] [Related]  

  • 25. Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.
    Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Kobayashi S; Sato A; Sugita R; Nagatake T
    J Clin Microbiol; 2001 Oct; 39(10):3775-7. PubMed ID: 11574616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.
    Hurdle JG; O'Neill AJ; Ingham E; Fishwick C; Chopra I
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4366-76. PubMed ID: 15504866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts.
    Manian FA
    Clin Infect Dis; 2003 Jan; 36(2):e26-8. PubMed ID: 12522764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methicillin-resistant Staphylococcus aureus (MRSA) with high resistance to mupirocin in hospitals of the Gdańsk region].
    Wiśniewska K; Dajnowska-Stanczewa A; Galiński J; Garbacz K
    Med Dosw Mikrobiol; 2002; 54(4):285-92. PubMed ID: 12650051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
    Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
    Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of Staphylococcus aureus isolated from burn wounds to mupirocin and other antibiotics.
    Bulanda M; Tomanek E; Sakiel S; Heczko PB
    J Chemother; 1989 Jul; 1(4 Suppl):395-6. PubMed ID: 16312456
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital.
    Yun HJ; Lee SW; Yoon GM; Kim SY; Choi S; Lee YS; Choi EC; Kim S
    J Antimicrob Chemother; 2003 Mar; 51(3):619-23. PubMed ID: 12615863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the polymerase chain reaction for rapid detection of high-level mupirocin resistance in staphylococci.
    Anthony RM; Connor AM; Power EG; French GL
    Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):30-4. PubMed ID: 10192711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.
    Driscoll DG; Young CL; Ochsner UA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2247-8. PubMed ID: 17438053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus.
    Farmer TH; Gilbart J; Elson SW
    J Antimicrob Chemother; 1992 Nov; 30(5):587-96. PubMed ID: 1493977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases.
    Gilbart J; Perry CR; Slocombe B
    Antimicrob Agents Chemother; 1993 Jan; 37(1):32-8. PubMed ID: 8431015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural changes induced by mupirocin in Staphylococcus aureus cells.
    Thomas DG; Hann AC; Day MJ; Wilson JM; Russell AD
    Int J Antimicrob Agents; 1999 Sep; 13(1):9-14. PubMed ID: 10563399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global analysis of the Staphylococcus aureus response to mupirocin.
    Reiss S; Pané-Farré J; Fuchs S; François P; Liebeke M; Schrenzel J; Lindequist U; Lalk M; Wolz C; Hecker M; Engelmann S
    Antimicrob Agents Chemother; 2012 Feb; 56(2):787-804. PubMed ID: 22106209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpretive criteria for testing susceptibility of staphylococci to mupirocin.
    Finlay JE; Miller LA; Poupard JA
    Antimicrob Agents Chemother; 1997 May; 41(5):1137-9. PubMed ID: 9145883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains.
    Fujimura S; Tokue Y; Watanabe A
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3373-4. PubMed ID: 14506063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.